Generating RWE for Optimising Market/Patient Access
With Prof. Dr Thomas Wilke
Course Details
THE CONTENT
Real-World Evidence (RWE) has become an essential addition to Randomised Controlled Trials (RCTs), helping to reduce uncertainty among regulators, payers, physicians, and patients. Yet, despite its growing importance, many pharmaceutical companies still struggle to implement RWE effectively across functions.
Success depends on a shared understanding of the fundamentals. Without a common vocabulary and baseline knowledge, cross-functional teams often face internal misalignment, slowing down RWE planning and decision-making.
This course provides a clear and practical introduction to RWE. You will learn the key concepts, study types, and use cases of real-world evidence, enabling you to contribute effectively to RWE-related decisions and projects, whether you are working directly in RWE or collaborating with RWE teams.
If you want to build a solid foundation in RWE and understand its strategic value across the product lifecycle, this course is a must-attend!
The training perfectly reflected the title and provided an excellent general overview of the RWD/RWE topic. I really valued the examples and the opportunity to ask questions. Thank you!
AOP Orphan Pharmaceuticals
Olga Shatilova, Clinical Development Manager - Austria - March 2025
THE EXPERT
Prof. Dr Thomas Wilke is a recognised expert in real-world evidence generation and an experienced academic.
He has over 25 years of experience leading RWE studies across Europe and Germany, including database analyses, linked data studies, medical chart reviews, and surveys.
In addition to his academic work and extensive publication record, Thomas leads the university-affiliated institute IPAM and serves as a senior scientist at GIPAM, a consultancy specialising in European RWE projects.
Thomas has been on CELforPharma’s faculty since 2023. He is consistently praised by participants for his clear and engaging teaching style, his deep expertise, and his pragmatic, real-world approach to RWE.
THE AUDIENCE & INTERACTIVE LEARNING FORMAT
This course is designed for pharma professionals who need a foundational understanding of RWE to collaborate effectively across functions. It is particularly valuable for:
Executives new to RWE or recently appointed to RWE teams
Cross-functional stakeholders such as:
Therapy area leads and brand leads
Market access leads
R&D and commercial team members
Pharma professionals not currently working in RWE but who interact with RWE functions
The interactive format combines expert-led learning with Q&A, peer discussions, and a group exercise based on a real-world RWE scenario. You will learn directly from Prof. Dr Thomas Wilke and collaborate with fellow participants to apply course learnings, gaining both clarity and confidence to engage meaningfully in RWE-related initiatives.
If you are a consultant, please contact Annelies Swaan, who will check with the faculty whether you can attend.
The course is highly valuable for anyone discovering what RWE is. I appreciated the clear definitions, the breakdown of data types and generation, and the trainer’s expertise. Everything was explained very well, with plenty of examples. The group workshop was a great way to increase interaction!
Servier
Sophie Grand-Perret, Responsible Learning & Development - France - March 2025
The expectations of external stakeholders regarding RWE throughout the product lifecycle.
The fundamental concepts, methodologies, and research techniques of RWE in the context of optimising Market Access.
Types of data and their strengths & weaknesses.
Critical success factors of an RWE study.
How to prepare for new developments in RWE generation.
A very clear and understandable course that provided a comprehensive view of the usefulness and design of RWE studies. I now have a better understanding of what RWE studies are, particularly their value from both a regulatory and market access standpoint. I appreciated the focus on best practices for designing RWE studies.
Pierre Fabre
Laurent Fredon, International Market Access Manager - France - March 2025
| Welcome & Introductions (~15 min) |
| Grasping the Full Spectrum of Stakeholder Needs and Uses of RWE (~1 h 30 min) |
|
| What You Need to Know About RWE Study Types and Data Sources (~1 h) |
|
| Lunch Break |
| Group Discussion: Your Experiences and Challenges With RWE Data/Studies (~30 min) |
| The Outcomes That RWE Studies Can Generate: Challenges & Best Practices (~1 h 45 min) |
|
| Understanding the Design and Statistical Analyses in RWE Studies (~30 min) |
|
| Guidelines For a Successful RWE Study & Group Exercise (~30 min) |
|
| Wrap-Up & Closing (~15 min) |
UPCOMING DATES & FORMATS - FEES
9 December 2025
Live online (CET timing)
Early bird € 1 470
(until 07/11/2025)
(Full fee € 1 670)
17 March 2026
Live online (CET timing)
Early bird € 1 570
(until 13/02/2026)
(Full fee € 1 770)
TIMING & LOCATION
Live Online (CET): Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
Live Online (EST): Zoom sessions between 8 AM and 4 PM EST (Eastern Standard Time).
Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan, Director Business Operations, for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses & self-study programme: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
The average Recommendation Score from participants of the last session was
8,6/10!
Testimonials from past participants:
A very clear and understandable course that provided a comprehensive view of the usefulness and design of RWE studies. I now have a better understanding of what RWE studies are, particularly their value from both a regulatory and market access standpoint. I appreciated the focus on best practices for designing RWE studies.
Pierre Fabre
Laurent Fredon, International Market Access Manager - France - March 2025
The training perfectly reflected the title and provided an excellent general overview of the RWD/RWE topic. I really valued the examples and the opportunity to ask questions. Thank you!
AOP Orphan Pharmaceuticals
Olga Shatilova, Clinical Development Manager - Austria - March 2025
The course is highly valuable for anyone discovering what RWE is. I appreciated the clear definitions, the breakdown of data types and generation, and the trainer’s expertise. Everything was explained very well, with plenty of examples. The group workshop was a great way to increase interaction!
Servier
Sophie Grand-Perret, Responsible Learning & Development - France - March 2025
Nice training for those working in, or having touchpoints with, RWE generation. As always, comprehensive and well-structured.
Femke Baeke, Medical Advisor - Belgium - March 2025
A colleague recommended CELforPharma, and he was right! Top quality course with an excellent speaker, thank you!
Viatris
Kareem Radwan, Head of Market Access, Channels & Reimbursement METL - United Arab Emirates - November 2024
The course met all the expectations I had, with a lot of opportunities to ask questions throughout. The wide range of topics covered in depth and the group exercise at the end were valuable for putting what we learned into practice. Dr Wilke was very engaging, and it was clear that he knows the subject really well.
Jazz Pharmaceuticals
Jamshaed Siddiqui, Senior Manager, HEOR, Europe & International - United Kingdom - June 2024
If you are looking for a training on the topic of generating RWE for Optimising Market/Patient Access, this is the perfect one for you! Every topic was delivered comprehensively and was covered from every angle with plenty of room for Q&A. The hands-on workshop was highly useful to put the theory of what we were learning into practice. The expert did a great job at presenting the course and also facilitating lots of interesting interaction throughout the day.
Bayer
Simone Caruso, Strategic Market Access Intelligence - Germany - June 2023
I definitely made the right choice by attending this training. I have learned so much and also have a good source of information I can look back on when needed in the future. It was very well organised by CELforPharma and excellently presented by the knowledgeable and professional presenter. Thank you all, it was truly an enjoyable and highly valuable day.
Galderma
Torun Bromée, Global Medical Franchise Lead - Sweden - June 2023
People attending this course are typically also interested in the below courses.
Need help to find the right course? Email Inge Cornelis (Director, Client & Product Projects) or call +32 473 65 15 77
We received very positive feedback from the team about Thomas (the expert) and the in-company session! Terrific, we all loved it and found it useful.
Merz Therapeutics
Selena Freisens, MD, Head of Global Medical Affairs - Germany - Generating RWE for Optimising Market/Patient Access
Course Details
Upcoming Session
9 December 2025, Live online (CET timing)
Early bird € 1 470
(until 07/11/2025)
(Full fee € 1 670)
Prices are excl. VAT
THE CONTENT
Real-World Evidence (RWE) has become an essential addition to Randomised Controlled Trials (RCTs), helping to reduce uncertainty among regulators, payers, physicians, and patients. Yet, despite its growing importance, many pharmaceutical companies still struggle to implement RWE effectively across functions.
Success depends on a shared understanding of the fundamentals. Without a common vocabulary and baseline knowledge, cross-functional teams often face internal misalignment, slowing down RWE planning and decision-making.
This course provides a clear and practical introduction to RWE. You will learn the key concepts, study types, and use cases of real-world evidence, enabling you to contribute effectively to RWE-related decisions and projects, whether you are working directly in RWE or collaborating with RWE teams.
If you want to build a solid foundation in RWE and understand its strategic value across the product lifecycle, this course is a must-attend!
The training perfectly reflected the title and provided an excellent general overview of the RWD/RWE topic. I really valued the examples and the opportunity to ask questions. Thank you!
AOP Orphan Pharmaceuticals
Olga Shatilova, Clinical Development Manager - Austria - March 2025
THE EXPERT
Prof. Dr Thomas Wilke is a recognised expert in real-world evidence generation and an experienced academic.
He has over 25 years of experience leading RWE studies across Europe and Germany, including database analyses, linked data studies, medical chart reviews, and surveys.
In addition to his academic work and extensive publication record, Thomas leads the university-affiliated institute IPAM and serves as a senior scientist at GIPAM, a consultancy specialising in European RWE projects.
Thomas has been on CELforPharma’s faculty since 2023. He is consistently praised by participants for his clear and engaging teaching style, his deep expertise, and his pragmatic, real-world approach to RWE.
THE AUDIENCE & INTERACTIVE LEARNING FORMAT
This course is designed for pharma professionals who need a foundational understanding of RWE to collaborate effectively across functions. It is particularly valuable for:
Executives new to RWE or recently appointed to RWE teams
Cross-functional stakeholders such as:
Therapy area leads and brand leads
Market access leads
R&D and commercial team members
Pharma professionals not currently working in RWE but who interact with RWE functions
The interactive format combines expert-led learning with Q&A, peer discussions, and a group exercise based on a real-world RWE scenario. You will learn directly from Prof. Dr Thomas Wilke and collaborate with fellow participants to apply course learnings, gaining both clarity and confidence to engage meaningfully in RWE-related initiatives.
If you are a consultant, please contact Annelies Swaan, who will check with the faculty whether you can attend.
The course is highly valuable for anyone discovering what RWE is. I appreciated the clear definitions, the breakdown of data types and generation, and the trainer’s expertise. Everything was explained very well, with plenty of examples. The group workshop was a great way to increase interaction!
Servier
Sophie Grand-Perret, Responsible Learning & Development - France - March 2025
The expectations of external stakeholders regarding RWE throughout the product lifecycle.
The fundamental concepts, methodologies, and research techniques of RWE in the context of optimising Market Access.
Types of data and their strengths & weaknesses.
Critical success factors of an RWE study.
How to prepare for new developments in RWE generation.
A very clear and understandable course that provided a comprehensive view of the usefulness and design of RWE studies. I now have a better understanding of what RWE studies are, particularly their value from both a regulatory and market access standpoint. I appreciated the focus on best practices for designing RWE studies.
Pierre Fabre
Laurent Fredon, International Market Access Manager - France - March 2025
| Welcome & Introductions (~15 min) |
| Grasping the Full Spectrum of Stakeholder Needs and Uses of RWE (~1 h 30 min) |
|
| What You Need to Know About RWE Study Types and Data Sources (~1 h) |
|
| Lunch Break |
| Group Discussion: Your Experiences and Challenges With RWE Data/Studies (~30 min) |
| The Outcomes That RWE Studies Can Generate: Challenges & Best Practices (~1 h 45 min) |
|
| Understanding the Design and Statistical Analyses in RWE Studies (~30 min) |
|
| Guidelines For a Successful RWE Study & Group Exercise (~30 min) |
|
| Wrap-Up & Closing (~15 min) |
UPCOMING DATES & FORMATS - FEES
9 December 2025
Live online (CET timing)
Early bird € 1 470
(until 07/11/2025)
(Full fee € 1 670)
17 March 2026
Live online (CET timing)
Early bird € 1 570
(until 13/02/2026)
(Full fee € 1 770)
TIMING & LOCATION
Live Online (CET): Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
Live Online (EST): Zoom sessions between 8 AM and 4 PM EST (Eastern Standard Time).
Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan, Director Business Operations, for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses & self-study programme: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
The average Recommendation Score from participants of the last session was
8,6/10!
Testimonials from past participants:
A very clear and understandable course that provided a comprehensive view of the usefulness and design of RWE studies. I now have a better understanding of what RWE studies are, particularly their value from both a regulatory and market access standpoint. I appreciated the focus on best practices for designing RWE studies.
Pierre Fabre
Laurent Fredon, International Market Access Manager - France - March 2025
The training perfectly reflected the title and provided an excellent general overview of the RWD/RWE topic. I really valued the examples and the opportunity to ask questions. Thank you!
AOP Orphan Pharmaceuticals
Olga Shatilova, Clinical Development Manager - Austria - March 2025
The course is highly valuable for anyone discovering what RWE is. I appreciated the clear definitions, the breakdown of data types and generation, and the trainer’s expertise. Everything was explained very well, with plenty of examples. The group workshop was a great way to increase interaction!
Servier
Sophie Grand-Perret, Responsible Learning & Development - France - March 2025
Nice training for those working in, or having touchpoints with, RWE generation. As always, comprehensive and well-structured.
Femke Baeke, Medical Advisor - Belgium - March 2025
A colleague recommended CELforPharma, and he was right! Top quality course with an excellent speaker, thank you!
Viatris
Kareem Radwan, Head of Market Access, Channels & Reimbursement METL - United Arab Emirates - November 2024
The course met all the expectations I had, with a lot of opportunities to ask questions throughout. The wide range of topics covered in depth and the group exercise at the end were valuable for putting what we learned into practice. Dr Wilke was very engaging, and it was clear that he knows the subject really well.
Jazz Pharmaceuticals
Jamshaed Siddiqui, Senior Manager, HEOR, Europe & International - United Kingdom - June 2024
If you are looking for a training on the topic of generating RWE for Optimising Market/Patient Access, this is the perfect one for you! Every topic was delivered comprehensively and was covered from every angle with plenty of room for Q&A. The hands-on workshop was highly useful to put the theory of what we were learning into practice. The expert did a great job at presenting the course and also facilitating lots of interesting interaction throughout the day.
Bayer
Simone Caruso, Strategic Market Access Intelligence - Germany - June 2023
I definitely made the right choice by attending this training. I have learned so much and also have a good source of information I can look back on when needed in the future. It was very well organised by CELforPharma and excellently presented by the knowledgeable and professional presenter. Thank you all, it was truly an enjoyable and highly valuable day.
Galderma
Torun Bromée, Global Medical Franchise Lead - Sweden - June 2023
People attending this course are typically also interested in the below courses.
Need help to find the right course? Email Inge Cornelis (Director, Client & Product Projects) or call +32 473 65 15 77
We received very positive feedback from the team about Thomas (the expert) and the in-company session! Terrific, we all loved it and found it useful.
Merz Therapeutics
Selena Freisens, MD, Head of Global Medical Affairs - Germany - Generating RWE for Optimising Market/Patient Access